Matches in Wikidata for { <http://www.wikidata.org/entity/Q59647823> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q59647823 description "article" @default.
- Q59647823 description "im Juli 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59647823 description "wetenschappelijk artikel" @default.
- Q59647823 description "наукова стаття, опублікована в липні 2005" @default.
- Q59647823 name "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 name "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 type Item @default.
- Q59647823 label "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 label "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 prefLabel "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 prefLabel "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 P1433 Q59647823-568BCCCB-8920-453D-9AB3-CB9BC8FF559E @default.
- Q59647823 P1476 Q59647823-2192215C-34C5-4EDC-BCCC-7BA42B393BDA @default.
- Q59647823 P2093 Q59647823-0EF10B6C-45FC-4F69-A3EA-2DB0392B588F @default.
- Q59647823 P2093 Q59647823-65C54F0F-8801-47CB-9FF2-B544F9AD7E96 @default.
- Q59647823 P2093 Q59647823-79630BF4-F1A3-4157-A1CE-12E61EA9ED38 @default.
- Q59647823 P2093 Q59647823-7C1B7586-1911-4469-AB2D-5F5B1A250C4A @default.
- Q59647823 P2093 Q59647823-8705F1DB-3F1E-4741-A9AE-F42221089D56 @default.
- Q59647823 P2093 Q59647823-8BF6F159-78F3-4ED9-AF7C-CE51EDB4C340 @default.
- Q59647823 P2093 Q59647823-DA3C63F6-E266-4773-9481-3EDED82FBE3C @default.
- Q59647823 P304 Q59647823-13BFAA7E-A4D2-4B79-834A-5D1E9E8FE4C9 @default.
- Q59647823 P31 Q59647823-2F27EBAB-0F8C-4AD4-8A38-80985EE3FF4D @default.
- Q59647823 P356 Q59647823-7A78121D-1558-47E5-B6C3-39FB3A68084F @default.
- Q59647823 P478 Q59647823-7A22FFB9-AA4F-4F52-9C44-150E1ECD6AD4 @default.
- Q59647823 P50 Q59647823-36FE60C6-BFBD-412B-B67F-2E8DE02DAA3F @default.
- Q59647823 P50 Q59647823-3F0B6DC7-B208-41A7-B690-FD56B9CB26E9 @default.
- Q59647823 P50 Q59647823-620B2AE8-F16D-49E2-AFBB-CA5A5F933898 @default.
- Q59647823 P50 Q59647823-E258FAB2-FFEB-4566-879A-0D05ECE33EDC @default.
- Q59647823 P577 Q59647823-76328857-3CD9-4D1F-B76B-5A363209AD2F @default.
- Q59647823 P921 Q59647823-1D274F53-5376-4359-BD83-8A7E7148C5D2 @default.
- Q59647823 P356 S0169-5002(05)80944-4 @default.
- Q59647823 P1433 Q641464 @default.
- Q59647823 P1476 "P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients" @default.
- Q59647823 P2093 "A. Bearz" @default.
- Q59647823 P2093 "C. Simonelli" @default.
- Q59647823 P2093 "E. Vaccher" @default.
- Q59647823 P2093 "G. Toffoli" @default.
- Q59647823 P2093 "M. Berretta" @default.
- Q59647823 P2093 "S. Spazzapan" @default.
- Q59647823 P2093 "U. Tirelli" @default.
- Q59647823 P304 "S235" @default.
- Q59647823 P31 Q13442814 @default.
- Q59647823 P356 "10.1016/S0169-5002(05)80944-4" @default.
- Q59647823 P478 "49" @default.
- Q59647823 P50 Q21255143 @default.
- Q59647823 P50 Q38546658 @default.
- Q59647823 P50 Q38546673 @default.
- Q59647823 P50 Q54252459 @default.
- Q59647823 P577 "2005-07-01T00:00:00Z" @default.
- Q59647823 P921 Q3658562 @default.